Agilent Technologies' Quarterly Earnings Preview
- Earnings per Share (EPS) forecast at $1.19, indicating a 6.3% decrease year-over-year.
- Expected revenue of $1.58 billion, representing an 8% decline from the same quarter last year.
- Stability in EPS estimates over the last 30 days suggests analyst confidence in Agilent's ability to meet expectations.
Agilent Technologies, trading under the symbol "A" on the NYSE, is gearing up for its quarterly earnings release on Wednesday, May 29, 2024, after the market closes. The company, known for its scientific instruments, is a key player in its industry, competing against other firms in the development and manufacturing of analytical instruments, software, services, and consumables for laboratories worldwide. As the earnings date approaches, Wall Street's eyes are on Agilent, with expectations set for an earnings per share (EPS) of $1.19 and revenue forecasts aiming at approximately $1.58 billion for the quarter.
The anticipation surrounding Agilent's earnings report is heightened by the fact that these figures represent a year-over-year decline. Specifically, the EPS forecast of $1.19 marks a 6.3% decrease from the previous year, while the expected revenue of $1.58 billion would signify an 8% drop from the same quarter last year. This downturn in both earnings and revenue highlights the challenges Agilent has faced over the past year, possibly due to market dynamics or internal factors affecting its performance.
Despite these anticipated declines, the stability in the consensus estimate for the EPS over the last 30 days is noteworthy. This stability suggests that analysts have not found reason to adjust their forecasts, indicating a consensus view on Agilent's performance for the quarter. This aspect is crucial for investors, as stability in earnings estimates can often signal confidence in the company's ability to meet expectations, which in turn can influence the stock's performance in the short term.
Moreover, Agilent's financial health, as reflected by its valuation ratios, provides a broader context for evaluating its upcoming earnings report. With a price-to-earnings (P/E) ratio of approximately 35.71, Agilent is seen as having a higher valuation compared to some of its peers. This high P/E ratio, along with a price-to-sales (P/S) ratio of about 6.56 and an enterprise value-to-sales (EV/Sales) ratio of around 6.70, indicates that investors are willing to pay a premium for Agilent's shares. These metrics, combined with a healthy liquidity position as shown by a current ratio of approximately 2.68, suggest that Agilent is well-positioned to navigate its current challenges.
As Agilent Technologies prepares to unveil its quarterly earnings, the focus will not only be on whether it meets or exceeds Wall Street's expectations but also on the insights provided by the management regarding the company's future outlook. The upcoming earnings report will be a critical moment for Agilent, potentially influencing its stock price and shaping investor sentiment based on its performance and strategic direction moving forward.
| Symbol | Price | %chg |
|---|---|---|
| PRDA.JK | 2560 | -0.39 |
| DHR-PB | 1261.26 | 0 |
| 2359.HK | 105 | 0.1 |
| TMO.NE | 20.45 | -1.52 |
Agilent Technologies (NYSE:A) Stock Analysis: Insights and Future Outlook
- Jefferies set a price target of $130 for Agilent Technologies (NYSE:A), while the stock was trading at $142.31, indicating a potential overvaluation according to Jefferies.
- Citi analysts maintain a 'Buy' rating on Agilent, with a target price of $165, highlighting the company's strong growth outlook and earnings leverage.
- Agilent's stock price has shown resilience with a current trading price of $141.64, reflecting a year-to-date increase amidst market fluctuations.
Agilent Technologies (NYSE:A) is a global leader in life sciences, diagnostics, and applied chemical markets. The company provides instruments, software, services, and consumables for the entire laboratory workflow. Agilent's competitors include Thermo Fisher Scientific and PerkinElmer. On October 3, 2025, Jefferies set a price target of $130 for Agilent, while the stock was trading at $142.31, indicating a price difference of approximately -8.65% from the target.
Citi analysts recently held a "constructive" meeting with Agilent's management, highlighting growth drivers for the company into the next year. These factors are expected to translate into earnings leverage, as noted by the analysts. Agilent's management expressed confidence in the company's growth outlook for fiscal 2026, supported by strong margins in its fiscal fourth quarter of 2025 and fiscal 2026.
Agilent is well-positioned to benefit from strong topline and volume growth, the Ignite initiative, and easing tariff impacts. Citi analysts have maintained a 'Buy' rating on Agilent's stock, setting a target price of $165 per share. Despite this positive outlook, Agilent shares experienced a slight decline of 0.5%, closing at $137.96 on Thursday.
Currently, Agilent's stock is priced at $141.64, reflecting an increase of 2.12% or $2.94. Today, the stock has traded as low as $138.86 and as high as $143.09. Over the past year, the stock has reached a high of $153.84 and a low of $96.43. The company has a market capitalization of approximately $40.16 billion, with a trading volume of 1,916,720 shares on the NYSE.
Agilent Beats Q4 Expectations but Posts Soft Guidance
Agilent Technologies (NYSE:A) reported fourth-quarter earnings that exceeded analyst expectations, but its fiscal 2025 guidance came in below projections.
For the quarter ending, Agilent posted adjusted earnings per share (EPS) of $1.46, surpassing the Street consensus estimate of $1.41. Revenue increased by 0.8% year-over-year to $1.70 billion, also beating the expected $1.67 billion. Despite the strong quarter, the company’s outlook dampened investor sentiment.
Agilent projected full-year fiscal 2025 adjusted EPS in the range of $5.54 to $5.61, falling short of the $5.66 analysts anticipated. Revenue guidance of $6.79 billion to $6.87 billion was roughly in line with the Street consensus estimate of $6.83 billion.
Looking ahead to the first quarter of 2025, Agilent forecast revenue between $1.65 billion and $1.68 billion, representing a range of -0.5% to +1.3% year-over-year growth. Adjusted EPS for the quarter is expected to fall between $1.25 and $1.28.
Agilent Beats Q4 Expectations but Posts Soft Guidance
Agilent Technologies (NYSE:A) reported fourth-quarter earnings that exceeded analyst expectations, but its fiscal 2025 guidance came in below projections.
For the quarter ending, Agilent posted adjusted earnings per share (EPS) of $1.46, surpassing the Street consensus estimate of $1.41. Revenue increased by 0.8% year-over-year to $1.70 billion, also beating the expected $1.67 billion. Despite the strong quarter, the company’s outlook dampened investor sentiment.
Agilent projected full-year fiscal 2025 adjusted EPS in the range of $5.54 to $5.61, falling short of the $5.66 analysts anticipated. Revenue guidance of $6.79 billion to $6.87 billion was roughly in line with the Street consensus estimate of $6.83 billion.
Looking ahead to the first quarter of 2025, Agilent forecast revenue between $1.65 billion and $1.68 billion, representing a range of -0.5% to +1.3% year-over-year growth. Adjusted EPS for the quarter is expected to fall between $1.25 and $1.28.
Agilent Technologies' Strong Q4 Financial Performance
- Agilent Technologies (NYSE:A) reported earnings per share (EPS) of $1.46, surpassing the estimated $1.41.
- The company's revenue for the quarter was approximately $1.7 billion, exceeding the estimated $1.67 billion.
- Agilent's financial health is indicated by a price-to-earnings (P/E) ratio of 29.84 and a current ratio of 2.09.
Agilent Technologies (NYSE:A) is a prominent player in the electronics testing equipment industry. The company specializes in providing analytical instruments, software, services, and consumables for the entire laboratory workflow. Agilent's competitors include Thermo Fisher Scientific and Danaher Corporation. The company recently reported its financial results for the fourth quarter of fiscal year 2024, showcasing its strong performance.
On November 25, 2024, Agilent reported earnings per share (EPS) of $1.46, surpassing the estimated $1.41. This marks a 3.55% earnings surprise, as highlighted by Zacks. The company has consistently outperformed consensus EPS estimates over the past four quarters, demonstrating its ability to exceed market expectations. In the previous quarter, Agilent also reported a positive earnings surprise of 5.60%.
Agilent's revenue for the quarter was approximately $1.7 billion, exceeding the estimated $1.67 billion. This represents a 1.65% revenue surprise, according to Zacks. The company has surpassed consensus revenue estimates in three of the last four quarters. Despite a slight decline of 0.3% in core revenue compared to the same quarter in 2023, Agilent's reported revenue increased by 0.8%.
During the Q4 2024 earnings call, CEO Padraig McDonnell and CFO Bob McMahon discussed the company's financial performance and strategic direction. Agilent's new market-based, customer-first strategy and organizational transformation are expected to enhance growth opportunities. The call was attended by analysts from major financial institutions, including Citi, Goldman Sachs, JPMorgan, and Bank of America.
Agilent's financial metrics provide insight into its market valuation and financial health. The company's price-to-earnings (P/E) ratio is approximately 29.84, while its price-to-sales ratio stands at about 5.94. The enterprise value to sales ratio is around 6.25, and the enterprise value to operating cash flow ratio is approximately 22.79. Agilent's debt-to-equity ratio is about 0.57, and its current ratio is around 2.09, indicating a strong ability to cover short-term liabilities.
Agilent Technologies' Strong Q4 Financial Performance
- Agilent Technologies (NYSE:A) reported earnings per share (EPS) of $1.46, surpassing the estimated $1.41.
- The company's revenue for the quarter was approximately $1.7 billion, exceeding the estimated $1.67 billion.
- Agilent's financial health is indicated by a price-to-earnings (P/E) ratio of 29.84 and a current ratio of 2.09.
Agilent Technologies (NYSE:A) is a prominent player in the electronics testing equipment industry. The company specializes in providing analytical instruments, software, services, and consumables for the entire laboratory workflow. Agilent's competitors include Thermo Fisher Scientific and Danaher Corporation. The company recently reported its financial results for the fourth quarter of fiscal year 2024, showcasing its strong performance.
On November 25, 2024, Agilent reported earnings per share (EPS) of $1.46, surpassing the estimated $1.41. This marks a 3.55% earnings surprise, as highlighted by Zacks. The company has consistently outperformed consensus EPS estimates over the past four quarters, demonstrating its ability to exceed market expectations. In the previous quarter, Agilent also reported a positive earnings surprise of 5.60%.
Agilent's revenue for the quarter was approximately $1.7 billion, exceeding the estimated $1.67 billion. This represents a 1.65% revenue surprise, according to Zacks. The company has surpassed consensus revenue estimates in three of the last four quarters. Despite a slight decline of 0.3% in core revenue compared to the same quarter in 2023, Agilent's reported revenue increased by 0.8%.
During the Q4 2024 earnings call, CEO Padraig McDonnell and CFO Bob McMahon discussed the company's financial performance and strategic direction. Agilent's new market-based, customer-first strategy and organizational transformation are expected to enhance growth opportunities. The call was attended by analysts from major financial institutions, including Citi, Goldman Sachs, JPMorgan, and Bank of America.
Agilent's financial metrics provide insight into its market valuation and financial health. The company's price-to-earnings (P/E) ratio is approximately 29.84, while its price-to-sales ratio stands at about 5.94. The enterprise value to sales ratio is around 6.25, and the enterprise value to operating cash flow ratio is approximately 22.79. Agilent's debt-to-equity ratio is about 0.57, and its current ratio is around 2.09, indicating a strong ability to cover short-term liabilities.
Agilent Technologies (NYSE:A) Quarterly Earnings Preview
- The anticipated EPS of $1.41 represents a 2.2% increase from the previous year.
- Projected revenue of $1.67 billion marks a slight decrease of 0.9% year-over-year.
- Options markets are pricing in a potential stock swing of 7.6% post-earnings.
Agilent Technologies (NYSE:A) is a global leader in life sciences, diagnostics, and applied chemical markets. The company provides instruments, software, services, and consumables for the entire laboratory workflow. As Agilent prepares to release its quarterly earnings on November 25, 2024, analysts expect an earnings per share (EPS) of $1.41 and revenue of $1.67 billion.
The anticipated EPS of $1.41 represents a 2.2% increase from the previous year, as highlighted by analysts. However, the projected revenue of $1.67 billion marks a slight decrease of 0.9% year-over-year. This stability in earnings estimates over the past 30 days suggests that analysts are confident in their forecasts, which can influence investor sentiment.
Historically, Agilent's stock has shown mixed reactions following earnings reports, with an equal number of positive and negative next-day returns over the past eight quarters. On average, the stock has moved 5.3% in either direction post-earnings in the last two years. However, options markets are currently pricing in a larger potential swing of 7.6% this time.
Agilent's stock price is currently up 0.9% at $126.83, recovering from its lowest close since July and potentially ending a four-day losing streak. The company's financial ratios, such as a P/E ratio of 27.10 and a price-to-sales ratio of 5.84, reflect investor confidence in its earnings and revenue potential. The debt-to-equity ratio of 0.50 indicates a moderate level of debt, while a current ratio of 1.78 suggests good liquidity.
Agilent Technologies (NYSE:A) Quarterly Earnings Preview
- The anticipated EPS of $1.41 represents a 2.2% increase from the previous year.
- Projected revenue of $1.67 billion marks a slight decrease of 0.9% year-over-year.
- Options markets are pricing in a potential stock swing of 7.6% post-earnings.
Agilent Technologies (NYSE:A) is a global leader in life sciences, diagnostics, and applied chemical markets. The company provides instruments, software, services, and consumables for the entire laboratory workflow. As Agilent prepares to release its quarterly earnings on November 25, 2024, analysts expect an earnings per share (EPS) of $1.41 and revenue of $1.67 billion.
The anticipated EPS of $1.41 represents a 2.2% increase from the previous year, as highlighted by analysts. However, the projected revenue of $1.67 billion marks a slight decrease of 0.9% year-over-year. This stability in earnings estimates over the past 30 days suggests that analysts are confident in their forecasts, which can influence investor sentiment.
Historically, Agilent's stock has shown mixed reactions following earnings reports, with an equal number of positive and negative next-day returns over the past eight quarters. On average, the stock has moved 5.3% in either direction post-earnings in the last two years. However, options markets are currently pricing in a larger potential swing of 7.6% this time.
Agilent's stock price is currently up 0.9% at $126.83, recovering from its lowest close since July and potentially ending a four-day losing streak. The company's financial ratios, such as a P/E ratio of 27.10 and a price-to-sales ratio of 5.84, reflect investor confidence in its earnings and revenue potential. The debt-to-equity ratio of 0.50 indicates a moderate level of debt, while a current ratio of 1.78 suggests good liquidity.
